# begin document GENTLE_medical_hiv
0	Description	(abstract-1)
1	:	_
2	Human	(abstract-2(animal-3-HIV
3	immunodeficiency	_
4	virus	animal-3-HIV)
5	disease	_
6	with	_
7	stable	_
8	control	_
9	on	_
10	Atripla	(substance-4-Efavirenz/emtricitabine/tenofovir)abstract-2)
11	.	_
12	Resolving	_
13	left	(object-5
14	gluteal	_
15	abscess	object-5)
16	,	_
17	completing	_
18	Flagyl	(substance-6-Metronidazole)
19	.	_
20	Diabetes	(abstract-7-Diabetes
21	mellitus	abstract-7-Diabetes)
22	,	_
23	currently	_
24	on	_
25	oral	(abstract-8
26	therapy	abstract-8)
27	.	_
28	Hypertension	(abstract-9)
29	,	_
30	depression	(abstract-10)
31	,	_
32	and	_
33	chronic	(abstract-11
34	musculoskeletal	_
35	pain	_
36	of	_
37	unclear	(abstract-12
38	etiology	abstract-11)abstract-12)
39	.	_
40	HISTORY	(abstract-13
41	OF	_
42	PRESENT	(abstract-2
43	ILLNESS	abstract-13)abstract-2)
44	:	_
45	The	(person-14
46	patient	person-14)
47	is	_
48	a	(person-14
49	41	_
50	-	_
51	year	_
52	-	_
53	old	_
54	white	_
55	male	_
56	with	_
57	a	(abstract-13
58	history	_
59	of	_
60	HIV	(abstract-2(animal-3-HIV)
61	disease	person-14)abstract-13)abstract-2)
62	.	_
63	His	(abstract-15(person-14)
64	last	_
65	CD4	(animal-16-CD4)
66	count	abstract-15)
67	was	_
68	425	(abstract-15)
69	,	_
70	viral	(abstract-17
71	load	abstract-17)
72	was	_
73	less	_
74	than	_
75	50	(abstract-18)
76	in	_
77	08	(time-19
78	/	_
79	07	time-19)
80	.	_
81	He	(person-14)
82	was	_
83	recently	_
84	hospitalized	_
85	for	_
86	left	(object-5
87	gluteal	_
88	abscess	_
89	,	_
90	for	_
91	which	_
92	he	(person-14)
93	underwent	_
94	I	(event-20
95	&	_
96	D	object-5)event-20)
97	and	_
98	he	(person-14)
99	has	_
100	newly	_
101	diagnosed	_
102	diabetes	(abstract-7-Diabetes
103	mellitus	abstract-7-Diabetes)
104	.	_
105	He	(person-14)
106	also	_
107	has	_
108	a	(abstract-21
109	history	_
110	of	_
111	hypertension	(abstract-9)
112	and	_
113	hypertriglyceridemia	(abstract-22)abstract-21)
114	.	_
115	He	(person-14)
116	had	_
117	been	_
118	having	_
119	increased	_
120	urination	(event-23)
121	and	_
122	thirst	(abstract-24)
123	.	_
124	He	(person-14)
125	was	_
126	seen	_
127	in	_
128	the	(place-25
129	hospital	place-25)
130	by	_
131	the	(person-26
132	endocrinology	_
133	staff	person-26)
134	and	_
135	treated	_
136	with	_
137	insulin	(substance-27)
138	while	_
139	hospitalized	_
140	and	_
141	getting	_
142	treatment	(abstract-28
143	for	_
144	his	(person-14)
145	perirectal	(object-5
146	abscess	abstract-28)object-5)
147	.	_
148	The	(organization-29
149	endocrine	_
150	team	organization-29)
151	apparently	_
152	felt	_
153	that	_
154	insulin	(substance-27)
155	might	_
156	be	_
157	best	_
158	for	_
159	this	(person-14
160	patient	person-14)
161	,	_
162	but	_
163	because	_
164	of	_
165	financial	(abstract-30
166	issues	abstract-30)
167	,	_
168	elected	_
169	to	_
170	place	_
171	him	(person-14)
172	on	_
173	Glucophage	(substance-31(substance-32-Metformin)
174	and	_
175	glyburide	(substance-33-Glibenclamide)substance-31)
176	.	_
177	The	(person-14
178	patient	person-14)
179	reports	_
180	that	_
181	he	(person-14)
182	has	_
183	been	_
184	taking	_
185	the	(substance-31
186	medication	substance-31)
187	.	_
188	He	(person-14)
189	is	_
190	in	_
191	general	_
192	feeling	_
193	better	_
194	.	_
195	He	(person-14)
196	says	_
197	that	_
198	his	(object-5(person-14)
199	gluteal	_
200	abscess	object-5)
201	is	_
202	improving	_
203	and	_
204	he	(person-14)
205	will	_
206	be	_
207	following	_
208	up	_
209	with	_
210	Surgery	(event-34)
211	today	(time-35)
212	.	_
213	CURRENT	(abstract-36
214	MEDICATIONS	abstract-36)
215	:	_
216	1.	_
217	Gabapentin	(substance-37-Gabapentin)
218	600	(substance-38
219	mg	substance-38)
220	at	_
221	night	(time-39)
222	.	_
223	2.	_
224	Metformin	(substance-40-Metformin)
225	1000	(substance-41
226	mg	substance-41)
227	twice	_
228	a	(time-42
229	day	time-42)
230	.	_
231	3.	_
232	Glipizide	(substance-43-Glipizide)
233	5	(substance-44
234	mg	substance-44)
235	a	(time-42
236	day	time-42)
237	.	_
238	4.	_
239	Flagyl	(substance-6-Metronidazole)
240	500	(substance-45
241	mg	substance-45)
242	four	_
243	times	_
244	a	(time-42
245	day	time-42)
246	.	_
247	5.	_
248	Flexeril	(substance-46-Cyclobenzaprine)
249	10	(substance-47
250	mg	substance-47)
251	twice	_
252	a	(time-42
253	day	time-42)
254	.	_
255	6.	_
256	Paroxetine	(substance-48-Paroxetine)
257	20	(substance-49
258	mg	substance-49)
259	a	(time-42
260	day	time-42)
261	.	_
262	7.	_
263	Atripla	(substance-4-Efavirenz/emtricitabine/tenofovir)
264	one	(object-50)
265	at	_
266	night	(time-39)
267	.	_
268	8.	_
269	Clonazepam	(substance-51-Clonazepam)
270	1	(substance-52
271	mg	substance-52)
272	twice	_
273	a	(time-42
274	day	time-42)
275	.	_
276	9.	_
277	Blood	(abstract-53(abstract-54(substance-55)
278	pressure	abstract-54)
279	medicine	abstract-53)
280	,	_
281	name	(abstract-56)
282	unknown	_
283	.	_
284	REVIEW	(abstract-57
285	OF	_
286	SYSTEMS	(abstract-58)abstract-57)
287	:	_
288	He	(person-14)
289	otherwise	_
290	has	_
291	a	(abstract-59
292	negative	_
293	review	_
294	of	_
295	systems	(abstract-58)abstract-59)
296	.	_
297	PHYSICAL	(abstract-60
298	EXAMINATION	abstract-60)
299	:	_
300	VITAL	(abstract-61
301	SIGNS	abstract-61)
302	:	_
303	Temperature	(abstract-62)
304	36.6	(abstract-62)
305	,	_
306	blood	(abstract-54(substance-55)
307	pressure	abstract-54)
308	145	(abstract-54
309	/	_
310	90	abstract-54)
311	,	_
312	pulse	(abstract-63)
313	123	(abstract-63)
314	,	_
315	respirations	(abstract-64)
316	20	(abstract-64)
317	,	_
318	and	_
319	weight	(abstract-65)
320	is	_
321	89.9	(abstract-65
322	kg	abstract-65)
323	(	_
324	198	(abstract-65
325	pounds	abstract-65)
326	.	_
327	)	_
328	HEENT	(abstract-66)
329	:	_
330	Unremarkable	_
331	except	_
332	for	_
333	some	(object-67
334	submandibular	_
335	lymph	_
336	nodes	object-67)
337	.	_
338	His	(object-68(person-14)
339	fundi	object-68)
340	are	_
341	benign	_
342	.	_
343	NECK	(object-69)
344	:	_
345	Supple	_
346	.	_
347	LUNGS	(object-70)
348	:	_
349	Clear	_
350	to	_
351	auscultation	(abstract-71)
352	and	_
353	percussion	(abstract-72)
354	.	_
355	CARDIAC	_
356	:	_
357	Reveals	_
358	regular	(abstract-73
359	rate	_
360	and	_
361	rhythm	(abstract-74
362	without	_
363	murmur	(event-75)
364	,	_
365	rub	(event-76)
366	or	_
367	gallop	(event-77)abstract-73)abstract-74)
368	.	_
369	ABDOMEN	(object-78)
370	:	_
371	Soft	_
372	and	_
373	nontender	_
374	without	_
375	organomegaly	(event-79)
376	or	_
377	mass	(object-80)
378	.	_
379	EXTREMITIES	(object-81)
380	:	_
381	Show	_
382	no	_
383	cyanosis	(event-82)
384	,	_
385	clubbing	(event-83)
386	or	_
387	edema	(event-84)
388	.	_
389	GU	_
390	:	_
391	Examination	(event-85
392	of	_
393	the	(object-86
394	perineum	event-85)object-86)
395	revealed	_
396	an	(object-5
397	open	_
398	left	_
399	gluteal	_
400	wound	_
401	that	_
402	appears	_
403	clear	_
404	with	_
405	no	(object-87
406	secretions	object-5)object-87)
407	.	_
408	IMPRESSION	(abstract-88)
409	:	_
410	1.	_
411	Human	(abstract-2(animal-3-HIV
412	immunodeficiency	_
413	virus	animal-3-HIV)
414	disease	_
415	with	_
416	stable	_
417	control	_
418	on	_
419	Atripla	(substance-4-Efavirenz/emtricitabine/tenofovir)abstract-2)
420	.	_
421	2.	_
422	Resolving	_
423	left	(object-5
424	gluteal	_
425	abscess	object-5)
426	,	_
427	completing	_
428	Flagyl	(substance-6-Metronidazole)
429	.	_
430	3.	_
431	Diabetes	(abstract-7-Diabetes
432	mellitus	abstract-7-Diabetes)
433	,	_
434	currently	_
435	on	_
436	oral	(abstract-8
437	therapy	abstract-8)
438	.	_
439	4.	_
440	Hypertension	(abstract-9)
441	.	_
442	5.	_
443	Depression	(abstract-10)
444	.	_
445	6.	_
446	Chronic	(abstract-11
447	musculoskeletal	_
448	pain	_
449	of	_
450	unclear	(abstract-12
451	etiology	abstract-11)abstract-12)
452	.	_
453	PLAN	(abstract-89)
454	:	_
455	The	(person-14
456	patient	person-14)
457	will	_
458	continue	_
459	his	(abstract-36(person-14)
460	current	_
461	medications	abstract-36)
462	.	_
463	He	(person-14)
464	will	_
465	have	_
466	laboratory	(abstract-90
467	studies	abstract-90)
468	done	_
469	in	_
470	3	(time-91
471	to	_
472	4	_
473	weeks	time-91)
474	,	_
475	and	_
476	we	(person-92)
477	will	_
478	see	_
479	him	(person-14)
480	a	(time-91
481	few	_
482	weeks	_
483	thereafter	time-91)
484	.	_
485	He	(person-14)
486	has	_
487	been	_
488	encouraged	_
489	to	_
490	keep	_
491	his	(event-93(person-14)
492	appointment	_
493	with	_
494	his	(person-94(person-14)
495	psychologist	event-93)person-94)
496	.	_
# end document

